Preface from the Editors-in-Chief
University of Toronto Medical Journal · 11.05.2026 · 103 (2)
DOI: 10.33137/utmj.v103i2.47567 ↗Kurz gefasst
Fachartikel in der Zeitschrift University of Toronto Medical Journal, online erschienen am 11.05.2026. Verfasst von Anna McCracken und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We are pleased to introduce Volume 103 Issue 2 of the University of Toronto Medical Journal (UTMJ): The Incretin Effect. A natural phenomenon first observed in the early 20th century, the incretin effect has been leveraged to drive the advent of therapies which have transformed the care of patients with metabolic disease and beyond. Since their clinical introduction, these therapies have transcended traditional boundaries in medicine and are continuing to do so rapidly. This era of incretin-based therapies is unprecedented; it represents the brilliance and creativity of leading minds in science, and also marks an important time to center intersecting social determinants of health in academic discourse.
Zitieren
APA
McCracken, A., & Meghdadi, Y. (2026). Preface from the Editors-in-Chief. University of Toronto Medical Journal, 103(2). https://doi.org/10.33137/utmj.v103i2.47567
Vancouver
McCracken A, Meghdadi Y. Preface from the Editors-in-Chief. University of Toronto Medical Journal. 2026;103(2). doi:10.33137/utmj.v103i2.47567
BibTeX
@article{McCracken2026,
author = {McCracken, Anna and Meghdadi, Yasmin},
title = {Preface from the Editors-in-Chief},
journal = {University of Toronto Medical Journal},
year = {2026},
volume = {103},
number = {2},
doi = {10.33137/utmj.v103i2.47567}
}
EUVIMED